The Knowledge Hub for Medical Imaging Professionals: Transforming Radiology with Structured Reporting, Data-Driven Approaches and Multicentric Research

Access breakthrough research, innovative case studies and collaborative projects advancing radiology worldwide. Dive into our activities and product updates, and learn who we are as a company and as a team.

Hands holding a glass lung to evoke image of lung cancer

Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing treatment response in melanoma and NSCLC patients receiving immune checkpoint inhibitors.

The results indicate that iRECIST is better suited for capturing atypical treatment responses to immunotherapies, especially in patients experiencing pseudoprogression. iRECIST could thus contribute to a more accurate evaluation of treatment response and improved immunotherapy outcomes.

Read more about the study here.

Related Resources

Related Resources

Someone reading a scientific publication on CT Radiomics, sarcopenia, gastric or esophageal cancer

CT-Radiomics unveils insights into sarcopenia's impact on esophageal and gastric cancer prognosis

Analyzing 83 patients with contrast-enhanced CT scans, University Hospital Ulm researchers tracked the prevalence of sarcopenia at different time…

mint Lesion screenshot with segmented muscles and radiomics

University Hospital Ulm: CT Radiomics and Machine Learning in Sarcopenia Evaluation for Esophageal and Gastric Cancer Patients

A recent study [1] conducted by researchers at University Hospital Ulm explored the role of sarcopenia in patients with esophageal or gastric cancer.…

Several juxtaposed images of different patients with different responses to the cancer treatment

Study with mint Lesion™ compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study conducted by researchers at University Hospital Tuebingen retrospectively compared two liver-targeted therapies for uveal melanoma patients…